Autopsy report · NCT06766435

Evaluation of the Abbott i-STAT TBI Biomarker Test

“Study was terminated early due to recruitment limitations and available funding for continued recruitment and follow up”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 4 months before it stopped.
• 42 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Icahn School of Medicine at Mount Sinai

Sponsor type

University, hospital or other

Conditions

Traumatic Brain Injury

Interventions

i-STAT TBI Test

Participants

42

Sites

3

Countries

United States

Trials that died the same way

• A Study to Determine the Performance of the Press Fit Condylar (P.F.C.) Sigma RP-F Knee System
  “Study was terminated early due to prolonged recruitment period.” (88% match in meaning)
• The Energy Dose Study
  “This study was halted pending additional funding and ultimately was terminated due to difficulties with ongoing recruitment, etc.” (86% match in meaning)
• Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
  “The study was terminated due to recruitment challenges” (86% match in meaning)
• Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab
  “Study was terminated early because of slow recruitment” (86% match in meaning)
• Alfuzosin Versus Placebo in Acute Urinary Retention
  “The study was early terminated due to slow and difficult recruitment” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.